Lycus Ltd., LLC Overview
Lycus Ltd. is a micro-cap, owner-operated specialty chemical manufacturer occupying a defensible niche within the global UV-absorber industry. From a single batch-chemistry plant in El Dorado, Arkansas, it synthesizes substituted benzophenones and cyano-diphenylacrylates, sold under the MAXGARD® brand to formulators of plastics, coatings, adhesives, polyester films, cosmetics, fragrances and food-contact materials. The company describes itself as the only domestic manufacturer of certain UV absorbers currently on the market, and a 2012 sell-side advisor characterized it as one of the few companies worldwide, and the only one in the United States, producing UV absorbers on these chemistries. It operates both as a branded wholesaler and as a contract/toll manufacturer for large chemical groups, including a supply relationship with BASF reported in 2017 to exceed 20 years. With roughly 20–22 employees, an exemplary safety record and exports to about a dozen countries, Lycus is best characterized as a cash-generative niche supplier rather than a growth platform.
What the company does
Lycus manufactures ultraviolet (UV) light absorbers and stabilizers: additives that customers blend into their own formulations so that finished goods resist UV-induced fading, discoloration, cracking, loss of adhesion and loss of fragrance [S1][S2]. The core chemistry is the substituted benzophenone family (Benzophenone-1, -2, -3, -6, -8, -9, -11, -12 and proprietary blends), complemented by two cyano-diphenylacrylates (etocrylene and octocrylene) and an aromatic intermediate, 1,3-dimethoxybenzene (RDME) [S1][S19][S21].
Company's own description (paraphrased from the latest website, © 2020)
The company presents itself as an Arkansas chemical plant producing UV absorbers for plastics, coatings, adhesives, polyester films, cosmetic product protection and personal care. It positions its products as preserving color, adhesive bond or fragrance that would otherwise degrade under UV exposure. It describes itself as both a wholesaler and contract manufacturer serving leading global chemical companies with "value-added technical service and logistics," and emphasizes its experienced workforce, process-engineering capability and quick customer response [S2]. No annual report exists; the website is the primary self-description.
Independent characterization
Lycus is a B2B intermediate/additive producer positioned mid-value-chain: it buys commodity aromatics and reagents (resorcinol, beta-resorcylic acid, anisoyl chloride, aluminum chloride, boron trifluoride, chlorosulfonic acid, solvents) and converts them via Friedel-Crafts-type acylation, etherification and sulfonation chemistry into specialty additives used at low dosages (typically 0.3–1.0% in formulations) [S2][S4]. Low dosage means customers are relatively price-insensitive per kilogram, but the business is exposed to substitution by larger producers' benzotriazole, triazine and HALS chemistries, and to regulatory pressure on certain benzophenones (notably Benzophenone-3/oxybenzone) in cosmetics.
The 2012 sale advisor (Grace Matthews) described Lycus as the smallest of three Syrgis subsidiaries but as a valuable, cash-generative asset operating in a protected niche, and noted the chemistries are highly engineered and hard to duplicate without significant R&D [S6].
Revenue model mix (qualitative; no figures disclosed)
| Revenue stream | Description | Evidence | Relative weight (analyst view) |
|---|---|---|---|
| Branded product sales (MAXGARD®) | Catalog products sold direct and via distributors | [S1][S16] | Likely majority |
| Contract / toll manufacturing | Custom synthesis for major chemical companies, including long-running BASF contract | [S2][S8] | Material; exact share not disclosed |
| Custom-specification grades | e.g., MAXGARD® 1800 formulated to a customer-specified K-value | [S5] | Embedded in product sales |
| Licensing / subscriptions | None identified | — | Nil |
Customer types and end-markets
| End-market (company-defined) | Example applications cited | Source |
|---|---|---|
| Cosmetics & personal care | Lip balm, lipstick, eye shadow, perfume, hair care, clear gels | [S1][S5] |
| Plastics, coatings & adhesives | PVC, polyester film, playground equipment, wood stains/varnishes, nitrocellulose lacquers, PU coatings, PSA adhesives | [S1][S4][S20] |
| Food contact substances (FCS) | Packaging protecting foods from light-induced rancidity | [S1][S3] |
| Greenhouses | Agricultural films (e.g., rose farms) | [S1] |
| Water-soluble applications | Surfactant-based cosmetics in clear containers | [S5] |
| Automotive / household / marine | Patio furniture, sailboats, tents, automotive parts | [S1] |
| Window film & textiles | Polyester window film and fabrics | [S4] |
Notable anecdotal end-use: the owner told the Arkansas Democrat-Gazette in 2017 that a Lycus product is used in a major luxury fragrance to extend shelf life [S8].
Strategy
The company publishes no annual report, investor-day material or formal strategy statement. Strategy is inferred from website positioning, award citations and press interviews.
Announced initiatives in the last 24 months (Oct 2024–Oct 2026): none publicly disclosed. Medium-term financial targets or guidance: none disclosed. ESG commitments: a Conflict Minerals Policy Statement (2020) [S2]; no emissions targets.
Products & Services
The company lists 15 MAXGARD® grades plus RDME [S1]. Pricing is not publicly disclosed for any product. Launch years are not disclosed; the line dates to roughly 1994–1997 [S2].
Services. Contract/toll manufacturing with hazardous or difficult reagents; custom-specification grades (e.g., K-value matching); technical service and logistics support [S2][S5]. Technical and safety data sheets are published in English, with Spanish versions for some grades [S4].
Distribution. Viachem Ltd. was appointed North American sales and distribution partner in 2009 [S16]; whether that agreement is still active is not disclosed. Products are also listed on SpecialChem and UL Prospector [S19][S20].
Product Portfolio
| Product | Chemistry | CAS | Form / key properties | Primary applications / target customers | Source |
|---|---|---|---|---|---|
MAXGARD® 300 | Benzophenone-6 (2,2'-dihydroxy-4,4'-dimethoxybenzophenone) | 131-54-4 † | Powder; typical use 0.3–1.0%; EINECS 205-027-3; HTS 2914.50 | Polyester window film/tint, polyester fabrics, inks, wood stains/varnishes, fluorescent paints/dyes, photographic emulsions | [S4][S21] |
MAXGARD® 400 | 2,4-Dihydroxybenzophenone (Benzophenone-1) | 131-56-6 ‡ | Powder | Coatings, nitrocellulose lacquers, varnishes, protective/marine coatings | [S19] |
MAXGARD® 500 | 2-Hydroxy-4-methoxybenzophenone (Benzophenone-3, oxybenzone) | 131-57-7 † | Powder | Nitrocellulose lacquers, varnishes, oil-based paints; cosmetics product protection | [S19][S21] |
MAXGARD® 600 | Proprietary benzophenone mixture | — | — | General light stabilizer | [S19] |
MAXGARD® 700 | 2-Hydroxy-4-n-octoxybenzophenone (Benzophenone-12) | 1843-05-6 † | Free-flowing light-yellow powder; m.p. 47–49 °C; density 1.16 g/cm³ | Polyurethanes, acrylic coatings, alkyd varnishes, vinyl and acrylic adhesives | [S20][S21] |
MAXGARD® 900 | 2,2'-Dihydroxy-4-methoxybenzophenone (Benzophenone-8, dioxybenzone) | 131-53-3 ‡ | Free-flowing light-yellow powder; m.p. 68–74 °C; density 1.37 g/cm³ | Oil-based paints, urethane coatings, pressure-sensitive acrylic/vinyl adhesives | [S20] |
MAXGARD® 1000 | Benzophenone-2 (2,2',4,4'-tetrahydroxybenzophenone) | 131-55-5 ‡ | Light-yellow powder; broad absorption into UV-A | PU coatings, oil paints, acrylic adhesives, UV-curing systems | [S19][S20] |
MAXGARD® 1030 | Benzophenone-11 (blend of BP-2 and BP-6) | Blend | Light-yellow powder; density 1.26 g/cm³ | Acrylic, polyester, rubber, PU, stains/varnishes, nitrocellulose lacquers, fluorescent pigments, photographic emulsions | [S1][S20] |
MAXGARD® 1800 | Benzophenone-9 (disodium sulfonate) | 76656-36-5 † | Water-soluble at 5%; custom K-value; EINECS 278-520-4; HTS 2914.70 | Cosmetics, perfumes, clear gels, hair care, surfactant systems in clear packaging | [S5] |
MAXGARD® 1888 | — | — | — | — | [S1] |
MAXGARD® 2700 | 100% active powder UV light stabilizer | — | Powder | Marketed as a replacement for TINUVIN® 328 (a benzotriazole) | [S21] |
MAXGARD® 2800 | — | — | — | — | [S1] |
MAXGARD® 2900 | — | — | — | — | [S1] |
MAXGARD® DPA-2 | Etocrylene (ethyl 2-cyano-3,3-diphenylacrylate) | 5232-99-5 † | White powder; good heat stability; little color contribution | Varnishes, nitrocellulose lacquers, PU, polyester gel coats, inks | [S19][S20][S21] |
MAXGARD® DPA-8 | Octocrylene (2-ethylhexyl 2-cyano-3,3-diphenylacrylate) | 6197-30-4 ‡ | 100% active clear light-amber viscous liquid; low color; extremely low volatility | Varnishes, lacquers, PU, acrylics, polyester gel coats, inks | [S19][S20] |
RDME | 1,3-Dimethoxybenzene | 151-10-0 ‡ | — | Aromatic intermediate (likely captive precursor and merchant sale) | [S1] |
UVITA SME 3811 | Formulation with a MAXGARD® key ingredient | — | Blue/indigo-light (400–440 nm) protection | Food-spoilage reduction under supermarket lighting; promoted in company technical note | [S3] |
“—” = not publicly disclosed.
Financial Narrative
Disclosure status. Lycus is a privately held single-member LLC. It files no audited financial statements publicly, has no SEC or state securities filings, and publishes no revenue, profit, balance-sheet or cash-flow data. Every metric below is not publicly disclosed. Cells are intentionally left blank, not zero, so automated charting treats them as missing.
Available proxies and commentary
Analyst commentary. No trend, inflection or driver analysis can be grounded in disclosed figures. Three structural inferences are reasonable. First, revenue per employee for a 21-person batch chemical plant would plausibly sit in the USD 0.5–1.2 million range by industry analogy, which is directionally consistent with the aggregator band; this is an inference, not data. Second, the 2012 MBO was described as structured "relatively quickly" by management with the seller [S6], which typically implies seller financing or a modest acquisition debt load that would since have amortized. Third, the plant's capital base (reactors of 4,000–11,000 L) is mature, suggesting maintenance-level capex. Revenue CAGR: not computable.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Proxy Segment Details
| Proxy segment | Contents | Key products |
|---|---|---|
Cosmetics & Personal Care | Product-protection UV absorbers, water-soluble grades | MAXGARD 500, 1800, DPA-8 |
Plastics, Coatings & Adhesives | Oil-soluble benzophenones and acrylates | MAXGARD 300, 400, 700, 900, 1000, 1030, 2700, DPA-2 |
Food Contact Substances | FCS-application grades | MAXGARD line (specific grades not disclosed) |
Greenhouses / Agriculture | Film stabilization | MAXGARD line |
Contract & toll manufacturing | Custom synthesis with difficult reagents | Customer-specific |
Intermediates | Aromatic intermediate | RDME (1,3-dimethoxybenzene) |
Financial Analysis
| Indicator | Value | Date | Reliability |
|---|---|---|---|
Revenue band (third-party estimate) | USD 10–25 million | Undated (current listing) | Low — modeled aggregator estimate |
Employee count | 21 | 2021 | High — state award citation |
Historical funding (group-level) | USD 24.1 million "raised", investors listed as Barings BDC, Edgewater Capital Partners, Greyrock Capital Group, Madison Capital Funding | Pre-2012 | Medium — almost certainly Syrgis-era leveraged buyout debt and PE equity, not current capital structure |
Group sale context | Two sister Syrgis subsidiaries sold for aggregate value above USD 100 million; Lycus the smallest of three | 2012 | High — advisor tombstone |
Cash generation | Characterized as generating "significant cash flow" | 2012 | Qualitative only |
Geographic Revenue
| Country | Region | Listed on website (2020+) | Named as export market (2017) |
|---|---|---|---|
United States | North America | Yes (home market) | — |
Canada | North America | Yes | No |
Mexico | Latin America | Yes | Yes |
Colombia | Latin America | Yes | No |
Spain | Europe | Yes | Yes |
Germany | Europe | Yes | Yes |
Poland | Europe | Yes | No |
Switzerland | Europe | No | Yes |
Saudi Arabia | Middle East | Yes | No |
India | Asia | Yes | Yes (described as "the big one") |
Bangladesh | Asia | Yes | No |
Japan | Asia | Yes | No |
South Korea | Asia | Yes | No |
Capital Markets
| Item | Status |
|---|---|
Share price performance (1/3/5-year) | Not applicable — private |
Analyst consensus | No coverage |
Dividend history / policy | Not applicable; owner distributions not disclosed |
Credit ratings (Moody's/S&P/Fitch) | Not rated |
Business credit file | Creditsafe safe number US17855463; risk score not publicly displayed |
Share price (USD) | FY2021 |
Analyst Conclusions
Management guidance and consensus
None. No guidance has been issued and no analyst consensus exists.
Bull case
-
Regulatory tailwind from benzotriazole restrictions. If MAXGARD® 2700 gains qualification as a UV-328 replacement [S21], Lycus could capture high-value substitution demand in plastics and coatings where incumbent chemistries face phase-out.
-
Reshoring premium. As the sole US producer of certain benzophenone/diphenylacrylate absorbers [S2][S6], Lycus can command supply-security pricing from US formulators seeking to reduce Asian dependence.
-
Diversification beyond cosmetics. Food-contact, greenhouse, water-soluble and blue-light niches [S1][S3][S5] reduce exposure to BP-3 cosmetic restrictions while drawing on the same plant and chemistry.
Bear case
-
Concentration risks compound. One plant, one owner and a significant anchor customer (BASF, itself a competitor) [S2][S8] mean any single adverse event could be existential.
-
Chemistry-class erosion. Several market reports place benzotriazoles ahead of benzophenones [S24], and personal-care regulation of BP-3 has tightened [S23]; Lycus's core franchise may be in slow structural decline.
-
Underinvestment. A website last refreshed in 2020 [S1], no announced initiatives in 24 months and no disclosed capex suggest a harvest posture rather than growth investment.
Catalysts and monitorables (next 12 months)
| Monitorable | Why it matters |
|---|---|
| Ownership or succession announcement | Owner has roughly 30 years with the company; a sale or recapitalization is plausible |
| BASF relationship status | Largest identifiable customer dependency |
| Commercial traction of MAXGARD® 2700 | Key growth lever from UV-328 phase-out |
| US tariff policy on chemical imports | Affects competitive position versus Asian benzophenones |
| Further EU/US restrictions on benzophenones | Downside risk to cosmetic grades |
| Process-safety and environmental record | Single-site risk; check EPA ECHO and OSHA records |
| Website or catalog refresh, new distributors | Signals reinvestment versus harvest |
Analyst verdict
Lycus Ltd. is not a public company and should be removed from any public-equity screen. It is a durable but very small owner-operated specialty-chemical manufacturer whose value lies almost entirely in process know-how, regulatory registrations, customer qualifications and a hard-to-replicate hazardous-chemistry plant in south Arkansas. Thirty-eight years after its founding as Garrison Industries, the business has survived three ownership regimes (founders, Edgewater/Syrgis private equity, and a 2012 management buyout). Through all of them it has held its claim to be the only US producer of certain substituted-benzophenone and diphenylacrylate UV absorbers, a claim made both by the company and, independently, by the advisor that ran its 2012 sale.
The evidence supports describing the business as cash-generative and stable, not growing. Employment has been flat at about 20–22 people since 2017. The product catalog and website have barely changed since 2020. The only third-party recognition in five years relates to export resilience and workplace safety. Revenue is undisclosed; the only external estimate (USD 10–25 million) is an unaudited aggregator band and should not be relied on.
The strategic tension is clear. On one side are regulatory and reshoring tailwinds, notably restrictions on benzotriazole UV-328 that MAXGARD® 2700 is designed to address, and supply-security demand for US-made additives. On the other are structural headwinds: tighter regulation of benzophenone-3 in cosmetics, Asian price competition, and dependence on a customer that is also a global competitor. Key-person and single-site concentration dominate the risk profile.
For counterparties, Lycus is a credible niche supplier with an exceptional safety record and ISO 9001 quality systems, but diligence should cover credit, continuity and succession. For acquirers, it is a plausible bolt-on target for a specialty-additives platform seeking US benzophenone capacity, with valuation driven by customer contracts and environmental condition of the site rather than growth.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Role | Tenure | Background |
|---|---|---|---|
John Sinclair | Owner (via John Sinclair Enterprises, LLC); de facto chief executive. Formal title not publicly disclosed. | Joined 1996 (finance); owner since 31 Aug 2012 | Hired to handle company finances in 1996; led the 2012 management buyout; represents the company at state export and safety awards |
Tasha Sinclair | Appears alongside the owner at award ceremonies and official visits; formal company role not disclosed | — | Spouse of owner |
Jimmy Wooten | Product Manager (as of 2009) | — | Quoted in the 2009 Viachem distribution announcement |
“—” = not publicly disclosed.
Major Shareholders
| Holder | Stake |
|---|---|
John Sinclair Enterprises, LLC | 100% of member units (since 31 Aug 2012) |
Institutional holders | None (private) |
Competitive Landscape
Key Competitors
| Competitor | HQ | Relevant products / chemistries | Overlap with Lycus | Relative positioning |
|---|---|---|---|---|
BASF SE | Germany | Tinuvin®, Uvinul® (benzotriazoles, triazines, HALS, benzophenones) | Coatings, plastics, cosmetics; also a Lycus customer | Global leader; vastly larger scale |
Clariant | Switzerland | Hostavin® light stabilizers | Plastics, coatings | Global specialty player |
SONGWON Industrial | South Korea | Polymer stabilizers including UV absorbers | Plastics, coatings | Major Asian polymer-additive supplier |
Everlight Chemical | Taiwan | Eversorb® UV absorbers | Plastics, coatings | Cost-competitive Asian specialist |
3V Sigma | Italy | Uvasorb® UV absorbers | Plastics, coatings, cosmetics | European mid-size specialist |
Mayzo | USA | Polymer additives, UV stabilizers | Plastics, coatings | US-based formulator/distributor |
SI Group | USA | Polymer stabilizers | Plastics | Diversified additives |
Symrise | Germany | Neo Heliopan® cosmetic UV filters (including BP-3, octocrylene) | Cosmetics | Strong in personal care |
DSM-Firmenich | Switzerland/Netherlands | Parsol® UV filters | Cosmetics | Strong in personal care |
Ashland | USA | Escalol® UV filters | Cosmetics | Personal-care specialist |
Chinese benzophenone producers (various) | China | BP-1, BP-3, BP-12 and other commodity benzophenones | All segments | Price setters in commoditized grades |
Peer Comparison FY2024
| Metric | Lycus Ltd. | BASF SE | Clariant | Symrise |
|---|---|---|---|---|
Group revenue, latest FY | Not disclosed (USD 10–25M third-party estimate) [S22] | ~EUR 65bn (FY2024) | ~CHF 4bn (FY2024) | ~EUR 5bn (FY2024) |
Revenue growth | — | See company filings | See company filings | See company filings |
Operating margin | — | See company filings | See company filings | See company filings |
R&D intensity | — | See company filings | See company filings | See company filings |
Employees | 21 (2021) [S3] |
| ~10,000 |
|
UV-absorber relevance | Core business (~100%) | Small share of group | Small share of group | Small share of group (cosmetic filters) |
“—” = not publicly disclosed.
Recent Developments
Extensive searching found no company-specific press releases, contract announcements, leadership changes, litigation or regulatory actions dated within the last 18 months. The company's website has not been materially updated since its 2020 relaunch apart from award postings [S1][S3].
Analyst note: * The absence of news is itself informative: Lycus operates as a low-profile, relationship-driven supplier, and material developments (customer wins or losses, pricing, capacity) would not normally be publicized.



